What is the lead time for production?

The lead time is 1-3 months for both peak and off-peak seasons.

What payment terms are accepted?

We accept LC, T/T, D/P, PayPal, small-amount payment, and Western Union.

Azithromycin Tablet 250mg

Name: Azithromycin Tablet 250mg
Brand: Shandong Shenglu Pharmaceutical Co., Ltd.
SKU: 2069018902

Shandong, ChinaShandong Shenglu Pharmaceutical Co., Ltd.

US$0.001

1-999 Pieces

US$0.01

1,000-9,999 Pieces

US$0.10

10,000+ Pieces

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For oral administration

Suitable for

Elderly, Adult

State

Solid

Shape

Tablet

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

SL12345

Drug Ad Approval No.

SL12345

Registration Dossiers

Available

Quality Standard

Bp or USP

Test Report

Available

Transport Package

10 Tablet Per Box, 200 Box Per Carton

Specification

250mg

Trademark

Shenglu

Origin

China

HS Code

300490

Production Capacity

1 Billion Per Year

Key features

250mg Strength: Each film-coated tablet contains 250mg Azithromycin for effective treatment.

Oral Administration: Designed for oral use with film-coated tablets suitable for adults and elderly.

Comprehensive Documentation: Includes COA, MOA, COPP, FSC, Stability Studies, GMP, and CTD Dossier.

OEM and ODM Services: Offers full customization, minor customization, and customization from samples or designs.

High Production Capacity: Annual capacity of 1 billion tablets and 500 million capsules with 7 production lines.

Quality Assurance: 100% inspection for finished products including visual and function checks.

Established Manufacturer: Founded in 1987 with over 220 staff and 20 years of export experience.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceIn-stock Capacity

Shandong Shenglu Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Full Customization CertifiedExport Year: 25 years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤11.21h

AI-Powered supplier vetting

SummaryThe supplier demonstrates substantial pharmaceutical production capacity, national GMP certification, stable-quality claims, broad customization, OEM/ODM services, export experience, inventory capacity, and documented complaint/CAPA procedures. However, it is not identified as a professional technical supplier, lacks 3D software and SDK capabilities, reported no new products in the past year, and has no overseas agents, branches, warehouses, showrooms, or offline trade-show participation. Financial records are referenced for 2021–2023, but the provided information does not establish financial strength. Supplier-approval documentation lacks signatures or dates, while environmental and fire-drill evidence remains unknown.

Supplier typeThe supplier is presented as a pharmaceutical manufacturer with stated capacity for small-volume injections, tablets, capsules, and powder injections, and it provides OEM/ODM services. It is explicitly not classified as a professional technical supplier, so its primary profile is manufacturing rather than technical-service provision.

CertificationsThe company description states that the supplier has passed national GMP certification. This is direct evidence of a relevant pharmaceutical manufacturing certification, although no additional certifications are provided.

After-Sales capabilityThe supplier has clear and followed procedures for customer complaints and corrective/preventive actions, and it maintains quality assurance. However, it has no overseas agents or branches, no overseas warehouse or showroom, and offers overseas services in zero countries, limiting evidence of broad international after-sales coverage.

R&D capabilityThe supplier does not provide 3D software design services, has no available SDK, and reported no new products in the past year. Although it offers ODM services and design-based customization, the explicit evidence indicates limited demonstrated product and technical innovation.

Production capacityThe supplier reports large annual pharmaceutical production capacity, inventory capability, valid manufacturing contracts with associated subcontractors, and national GMP certification. These points directly support substantial and organized manufacturing capability.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, and minor customization, as well as ODM services. This demonstrates broad customization coverage despite the absence of 3D software design services.

Client casesThe supplier reports that 71%–90% of total sales come from exports, has exported goods for 20 years, and provides OEM services for well-known brands. These statements support relevant customer and international business experience, although specific customer names or case details are not supplied.